Sphingotec GmbH
http://www.sphingotec.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sphingotec GmbH
End Game: Adrenomed Targets Global Reach For Sepsis Candidate
German biotech Adrenomed has proof-of-concept data showing its sepsis drug can cut mortality by 67%. Now, it needs money to move the candidate into Phase IIb/III trials.
Wellington Partners Unveils €210m Eurocentric Biotech/Medtech Fund WPLS-V
With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.
Medical Device Deals Update, November-December 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2014.
Company Information
- Industry
- Biotechnology
-
In Vitro Diagnostics
- Chemistry, Immunoassay
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice